CN112067707A - Method for detecting vitamin E in multi-vitamin tablets - Google Patents
Method for detecting vitamin E in multi-vitamin tablets Download PDFInfo
- Publication number
- CN112067707A CN112067707A CN202010273583.0A CN202010273583A CN112067707A CN 112067707 A CN112067707 A CN 112067707A CN 202010273583 A CN202010273583 A CN 202010273583A CN 112067707 A CN112067707 A CN 112067707A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- mixed sample
- sample
- detecting
- pretreatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title claims abstract description 97
- 229930003427 Vitamin E Natural products 0.000 title claims abstract description 48
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 title claims abstract description 48
- 229940046009 vitamin E Drugs 0.000 title claims abstract description 48
- 239000011709 vitamin E Substances 0.000 title claims abstract description 48
- 235000019165 vitamin E Nutrition 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims abstract description 33
- 229940088594 vitamin Drugs 0.000 title claims description 9
- 239000011782 vitamin Substances 0.000 title claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 51
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 108091005804 Peptidases Proteins 0.000 claims abstract description 21
- 239000004365 Protease Substances 0.000 claims abstract description 21
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 21
- 238000001914 filtration Methods 0.000 claims abstract description 13
- 238000009210 therapy by ultrasound Methods 0.000 claims abstract description 12
- 238000007865 diluting Methods 0.000 claims abstract description 10
- 239000013558 reference substance Substances 0.000 claims abstract description 10
- 238000001816 cooling Methods 0.000 claims abstract description 8
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 27
- 230000008569 process Effects 0.000 abstract description 9
- 230000000052 comparative effect Effects 0.000 description 36
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 102000005158 Subtilisins Human genes 0.000 description 6
- 108010056079 Subtilisins Proteins 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 238000007127 saponification reaction Methods 0.000 description 6
- 238000009736 wetting Methods 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000002203 pretreatment Methods 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000010812 external standard method Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- 229960000355 copper sulfate Drugs 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000011755 sodium-L-ascorbate Substances 0.000 description 1
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8675—Evaluation, i.e. decoding of the signal into analytical information
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N2030/042—Standards
- G01N2030/047—Standards external
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Library & Information Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention aims to provide a detection method capable of quickly and effectively extracting vitamin E in multi-dimensional tablets in pretreatment, which adopts enzymolysis for pretreatment and comprises the following steps: step 1, adding water to wet a multi-dimensional sheet sample, adding a predetermined amount of protease, and shaking up to obtain a mixed sample I; step 2, placing the mixed sample I in a water bath with a preset temperature for ultrasonic preset time, and then adding a preset amount of ethanol to obtain a mixed sample II; step 3, continuing ultrasonic treatment on the mixed sample II at a preset temperature for preset time, cooling to room temperature, and diluting with ethanol to obtain a mixed sample III; and 4, filtering the mixed sample III, detecting by adopting HPLC, and calculating based on a reference substance detected by adopting HPLC to obtain the content of the vitamin E in the sample. The method adopts protease for enzymolysis pretreatment, so that the loss of vitamin E in the pretreatment process can be reduced, and the detection result is more accurate.
Description
Technical Field
The invention belongs to the field of health care products, relates to a detection method of vitamin, and particularly relates to a detection method of vitamin E in a multi-vitamin tablet.
Background
The multivitamin tablet is a health product tablet containing multiple vitamins, and is usually composed of multiple vitamins and auxiliary materials with different components. Accurate detection of different kinds of vitamins in a multi-dimensional tablet is necessary to ensure the product quality.
Some multi-vitamin tablets contain vitamin E, the vitamin E is unstable in property and easy to oxidize, common solid raw materials in the industry are subjected to oxidation resistance by adopting an embedding technology, and an embedding layer needs to be broken first during detection, so that the detection is difficult. In the prior art, the detection of vitamin E mostly adopts Gas Chromatography (GC) or High Performance Liquid Chromatography (HPLC), and certain pretreatment is needed before the determination so as to separate the vitamin E from a sample to be detected. For example, the national standard (GB5009.82-2016) specifies a method for detecting vitamin E contained in food, which comprises the steps of saponifying and then extracting, concentrating the obtained organic phase, filtering and measuring by HPLC. The method has more steps and complicated operation, has higher requirements on the operation experience and skill of a person due to longer process, and the vitamin E is easy to generate content change due to oxidation and other reasons during the process, thereby influencing the accuracy of the final determination result. Moreover, for health care products with complex components such as multi-dimensional tablets, the pretreatment method of saponification extraction is difficult to effectively extract vitamin E, so that the final detection result has larger error.
Disclosure of Invention
In order to solve the problems, the invention provides a detection method capable of quickly and effectively extracting vitamin E in multi-dimensional tablets in pretreatment, which is characterized in that a protein embedding layer is destroyed by constant temperature enzymolysis, and then the pretreatment is carried out by directly extracting with an organic solvent, and the detection method comprises the following steps: step 1, adding water to wet a multi-dimensional sheet sample, adding a predetermined amount of protease, and shaking up to obtain a mixed sample I; step 2, placing the mixed sample I in a water bath with a preset temperature for ultrasonic preset time, and then adding a preset amount of ethanol to obtain a mixed sample II; step 3, continuing ultrasonic treatment on the mixed sample II at a preset temperature for preset time, cooling to room temperature, and diluting with ethanol to obtain a mixed sample III; and 4, filtering the mixed sample III, detecting by adopting HPLC, and calculating based on a reference substance detected by adopting HPLC to obtain the content of the vitamin E in the sample.
The method for detecting vitamin E in the multi-dimensional tablets provided by the invention can also have the technical characteristics that the preset temperature in the step 2 and the step 3 is 60-65 ℃, and the preset time in the step 2 and the step 3 is 20 min.
The method for detecting vitamin E in the multi-dimensional tablet provided by the invention can also have the technical characteristics that the volume mass ratio of the protease added in the step 1 to the sample is 1: 1-5: 1.
The method for detecting vitamin E in the multi-dimensional tablets provided by the invention can also have the technical characteristics that the enzymatic activity of the protease used in the step 1 is more than or equal to 3 AU-A/g.
Action and Effect of the invention
According to the method for detecting the vitamin E in the multi-dimensional tablets, the protease is adopted for enzymolysis pretreatment, and the enzymolysis process is carried out under the ultrasonic condition of 60-65 ℃, so that the loss of the vitamin E in the pretreatment process can be reduced, the requirement on experience of operators is low, a transfer extraction step is avoided, samples are basically free of loss, and the detection result is more accurate. In addition, the pretreatment process is simple to operate and short in time consumption, and the rapid and accurate detection of the vitamin E in the multi-dimensional tablets can be realized.
Detailed Description
The following describes specific embodiments of the present invention.
In the following examples and comparative examples, the vitamin E reference substance was obtained from the institute of medical sciences and has a purity of 98%; the protease manufacturer is novozymes; other reagents were obtained by general commercial procurement, and the conditions and operation were not specified, referring to the conventional techniques. In addition, the multi-dimensional tablets used in the examples and comparative examples were self-made by the applicant and comprised, as main components: calcium carbonate, manganese sulfate, ferrous fumarate, zinc sulfate, sodium selenite, copper sulfate, retinyl acetate, vitamin D3, thiamine nitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamine, nicotinamide, folic acid, D-biotin, L-ascorbic acid, sodium L-ascorbate, calcium D-pantothenate, dl-alpha-tocopherol acetate, dl-alpha-tocopherol (vitamin E), microcrystalline cellulose, sodium starch octenyl succinate, maltodextrin, silicon dioxide, acacia gum, croscarmellose sodium, magnesium stearate, white granulated sugar, hydroxypropyl methyl cellulose, low-substituted hydroxypropyl cellulose, edible corn starch, tricalcium phosphate, citric acid, sodium citrate, caprylic acid, capric glyceride and a coating premix.
< example >
The detection method of vitamin E in the multi-dimensional tablets comprises the following steps:
step 1, putting 0.3g of a multidimensional sheet sample into a 50ml brown volumetric flask, adding 3ml of water for wetting, adding 0.8g of protease (novozymes Alcalase 3.0T), and shaking up to obtain a mixed sample I;
step 2, placing the mixed sample I in a water bath at the temperature of 60-65 ℃ for ultrasonic treatment for 20min, and then adding 40ml of ethanol to obtain a mixed sample II;
step 3, continuing to perform ultrasonic treatment on the mixed sample II in a water bath at the temperature of 60-65 ℃ for 20min, cooling to room temperature, diluting to a scale with ethanol, and fully shaking up to obtain a mixed sample III;
and 4, filtering the mixed sample III by using a 0.45-micron filter membrane, detecting by using HPLC, and calculating based on a reference substance detected by using HPLC to obtain the content of the vitamin E in the sample.
In this example, the HPLC conditions for step 4 were as follows:
high performance liquid chromatograph: agilent, type 1260;
a chromatographic column: ZORBAX SB-C18;
mobile phase: methanol: water 98: 2
Flow rate: 1.0ml/min
Sample introduction amount: 100 μ L
Detection wavelength: 264nm
Column temperature: 30 deg.C
In this embodiment, an external standard method is used for content calculation, and the specific operations are as follows: and (4) taking a vitamin E control product, diluting the vitamin E control product by using the HPLC mobile phase to a sample equivalent concentration, and detecting by adopting the HPLC condition. And (3) filtering the mixed sample III, calculating the peak area obtained by HPLC detection by using an external standard method formula to obtain the concentration of the vitamin E in the mixed sample III, and then converting to obtain the content of the vitamin E in the multi-dimensional tablet sample.
< comparative example 1>
The method for detecting vitamin E in the multi-dimensional tablets of comparative example 1 comprises the following steps:
step 1, taking 0.3g of a multi-dimensional sheet sample, placing the multi-dimensional sheet sample in a 50ml brown volumetric flask, adding 3ml of water for wetting, adding 1.0ml of protease (novozymes Alcalase 3.0T or the same enzyme with the enzyme activity more than or equal to 3AU-A/g) for shaking uniformly to obtain a mimutexed sample I;
step 2, placing the mixed sample I in a water bath at the temperature of 60-65 ℃ for heating for 20min, and then adding 40ml of ethanol to obtain a mixed sample II;
step 3, continuing to heat the mixed sample II in a water bath at the temperature of 60-65 ℃ for 20min, cooling to room temperature, diluting to a scale with ethanol, and fully shaking up to obtain a mixed sample III;
and 4, filtering the mixed sample III by using a 0.45-micron filter membrane, detecting by using HPLC, and calculating based on a reference substance detected by using HPLC to obtain the content of the vitamin E in the sample.
The HPLC conditions used in this comparative example were the same as those in the examples.
As described above, the present comparative example differs from the examples mainly in that only the mixed sample is heated without being subjected to ultrasonication in step 2 and step 3.
< comparative example 2>
The method for detecting vitamin E in the multi-dimensional tablets of comparative example 2 comprises the following steps:
step 1, taking 0.3g of a multi-dimensional sheet sample, placing the multi-dimensional sheet sample in a 50ml brown volumetric flask, adding 3ml of water for wetting, adding 1.0ml of protease (novozymes Alcalase 3.0T or the same enzyme with the enzyme activity more than or equal to 3AU-A/g) for shaking uniformly to obtain a mimutexed sample I;
step 2, placing the mixed sample I in a room-temperature water bath for ultrasonic treatment for 20min, and then adding 40ml of ethanol to obtain a mixed sample II;
step 3, continuing to perform ultrasonic treatment on the mixed sample II in a room-temperature water bath for 20min, diluting the mixed sample II to a scale with ethanol, and fully shaking up to obtain a mixed sample III;
and 4, filtering the mixed sample III by using a 0.45-micron filter membrane, detecting by using HPLC, and calculating based on a reference substance detected by using HPLC to obtain the content of the vitamin E in the sample.
The HPLC conditions used in this comparative example were the same as those in the examples.
As described above, the present comparative example differs from the examples mainly in that the temperature condition when only the mixed sample is subjected to ultrasonication in step 2 and step 3 is room temperature.
< comparative example 3>
The method for detecting vitamin E in the multi-dimensional tablets of comparative example 3 comprises the following steps:
step 1, taking 0.3g of a multi-dimensional sheet sample, placing the multi-dimensional sheet sample in a 50ml brown volumetric flask, adding 3ml of water for wetting, adding 1.0ml of protease (novozymes Alcalase 3.0T or the same enzyme with the enzyme activity more than or equal to 3AU-A/g) for shaking uniformly to obtain a mimutexed sample I;
step 2, standing the mixed sample I at room temperature for 20min, and then adding 40ml of ethanol to obtain a mixed sample II;
step 3, shaking the mixed sample II uniformly, continuing standing at room temperature for 20min, diluting with ethanol to a scale, and fully shaking uniformly to obtain a mixed sample III;
and 4, filtering the mixed sample III by using a 0.45-micron filter membrane, detecting by using HPLC, and calculating based on a reference substance detected by using HPLC to obtain the content of the vitamin E in the sample.
The HPLC conditions used in this comparative example were the same as those in the examples.
As described above, the comparative example differs from the examples mainly in that the mixed sample was not subjected to sonication nor heated in step 2 and step 3.
< comparative example 4>
The method for detecting vitamin E in the multi-dimensional tablets of comparative example 4 comprises the following steps:
step 1, putting 0.3g of a multidimensional sheet sample into a 50ml brown volumetric flask, adding 3ml of water for wetting, and shaking up to obtain a mixed sample I;
step 2, placing the mixed sample I in a water bath at the temperature of 60-65 ℃ for heating and ultrasonic treatment for 20min, and then adding 40ml of ethanol to obtain a mixed sample II;
step 3, continuing heating and ultrasonic treating the mixed sample II in a water bath at the temperature of 60-65 ℃ for 20min, cooling to room temperature, diluting to a scale with ethanol, and fully shaking up to obtain a mixed sample III;
and 4, filtering the mixed sample III by using a 0.45-micron filter membrane, detecting by using HPLC, and calculating based on a reference substance detected by using HPLC to obtain the content of the vitamin E in the sample.
The HPLC conditions used in this comparative example were the same as those in the examples.
As described above, the comparative example differs from the examples mainly in that no protease was added to the sample, that is, no enzymatic hydrolysis was performed.
< comparative example 5>
The vitamin E in the multi-dimensional tablets of the comparative example 5 is detected by adopting a national standard method, and the method specifically comprises the following steps:
saponification: weighing a proper amount of homogenized multidimensional slice solid sample into a 150mL flat-bottomed flask, adding about 20mL warm water, mixing uniformly, adding 1.0g ascorbic acid and 0.1g BHT, mixing uniformly, adding 30mL absolute ethyl alcohol, adding 10 mL-20 mL potassium hydroxide solution, shaking while adding, shaking, mixing uniformly, oscillating soap in a constant-temperature water bath at 80 ℃ for 30min, and immediately cooling to room temperature by cold water after saponification.
And (3) extraction: transferring the saponified solution into 250mL separating funnel with 30mL water, adding 50mL petroleum ether-ether mixture, shaking for 5min, transferring the lower layer solution into another 250mL separating funnel, adding 50mL mixed ether solution, extracting again, and combining ether layers.
Washing: the ether layer was washed with about 100mL of water and repeated about 3 times until the ether layer was washed neutral (the pH of the lower solution was checked using pH paper) and the lower aqueous phase was removed.
Concentration: filtering the washed ether layer into a 250mL rotary evaporation bottle or a nitrogen concentration tube through anhydrous sodium sulfate (about 3g), flushing a separating funnel and the anhydrous sodium sulfate for 2 times by using about 15mL petroleum ether, merging the mixture into the evaporation bottle, connecting the evaporation bottle onto a rotary evaporator or a gas concentrator, carrying out reduced pressure distillation or gas flow concentration in a water bath at 40 ℃ or carrying out gas flow concentration, taking down the evaporation bottle when about 2mL of ether liquid in the bottle is left, and immediately blowing the evaporation bottle to be nearly dry by using nitrogen. The residue in the evaporation flask was dissolved with methanol in portions and transferred to a 10mL volumetric flask to volume. The solution was passed through a 0.22 μm organic filter and subjected to HPLC.
The HPLC conditions and the calculation method of the content used in this comparative example are the same as those in the examples.
< comparative example 6>
The method for detecting vitamin E in the multi-dimensional tablets of comparative example 6 comprises the following steps:
step 1, putting 0.3g of a multidimensional slice sample into a 50ml brown volumetric flask, adding 3ml of water for wetting, adding 0.8g of protease (Tengheng 20 ten thousand enzyme active protease; the enzyme activity is less than 3AU-A/g) for shaking uniformly to obtain a mimutexed sample I;
step 2, placing the mixed sample I in a water bath at the temperature of 60-65 ℃ for ultrasonic treatment for 20min, and then adding 40ml of ethanol to obtain a mixed sample II;
step 3, continuing to perform ultrasonic treatment on the mixed sample II in a water bath at the temperature of 60-65 ℃ for 20min, cooling to room temperature, diluting to a scale with ethanol, and fully shaking up to obtain a mixed sample III;
and 4, filtering the mixed sample III by using a 0.45-micron filter membrane, detecting by using HPLC, and calculating based on a reference substance detected by using HPLC to obtain the content of the vitamin E in the sample.
The HPLC conditions used in this comparative example were the same as those in the examples.
Effects and effects of the embodiments
The multidimensional slices of the same batch were tested by the methods of the above examples and comparative examples, each method was performed in 6 replicates, and the test results are shown in table 1 below. In table 1, the data of the 6 parallel detection results are separated by a semicolon.
As shown in Table 1, the average value of the test results of the examples was 26mg/g for the same lot of multi-dimensional sheet samples.
Compared with the examples, the detection results of the comparative examples 1 to 3 are about 20mg/g and lower than the detection results of the examples. After protease is added, the ultrasonic treatment is not carried out in the comparative example 1, the heating treatment is not carried out in the comparative example 2, and the heating treatment and the ultrasonic treatment are not carried out in the comparative example 3.
Compared with the examples and the comparative examples 1 to 3, the comparative example 4 is not added with protease, which means that no enzymolysis treatment exists, and the detection result of the comparative example 4 is about 14mg/g, which is far lower than that of the examples and is obviously lower than that of the comparative examples 1 to 3, which shows that although the enzymolysis treatment in the comparative examples 1 to 3 is insufficient, the insufficient enzymolysis treatment still has a certain effect of reducing the loss in the pretreatment process. In addition, novozymes Alcalase 3.0T is adopted for enzymolysis in the embodiment, but further emutexperiments show that the same kind of enzyme with the enzyme activity being more than or equal to 3AU-A/g can achieve the same detection effect, the detection result is basically the same as the embodiment, and the description is omitted.
The detection method of the comparative example 5 adopts the saponification pretreatment method of the national standard in the prior art, the detection result is about 23mg/g, which is lower than that of the embodiment, and the effect of the pretreatment method of the embodiment on loss reduction is better than that of the saponification pretreatment method in the prior art.
The test method of comparative emutexample 6 was the same as in emutexample emutexcept that an active enzyme having an enzyme activity of < 3AU-A/g was used, and the result was lower than that of emutexample. This result indicates that the recovery of the assay is lower when treated with protease of lower enzyme activity, probably because the magnitude of the enzyme activity correlates with the degree of reduction of pretreatment loss. Correspondingly, the novozymes Alcalase 3.0T or similar enzymes with the enzyme activity more than or equal to 3AU-A/g are adopted for enzymolysis treatment, so that the loss in pretreatment can be reduced, and the final detection result is more consistent with the actual content of the vitamin E in the multi-dimensional tablets.
In summary, in the method for detecting vitamin E in a multi-dimensional tablet of the embodiment, since the protease with the enzyme activity of not less than 3AU-a/g is used for the pretreatment of the enzymolysis, and the enzymolysis process is performed under the ultrasonic condition of 60-65 ℃, the loss of the vitamin E in the pretreatment process can be reduced, so that the detection result is more accurate. In addition, the pretreatment operation of the embodiment mainly comprises enzymolysis, dilution and filtration, and compared with saponification, extraction, concentration and the like in the prior art, the method is simpler in operation, shorter in time consumption, lower in experience requirement on operators, and capable of realizing rapid and accurate detection of vitamin E in the multi-dimensional tablet.
Claims (4)
1. A method for detecting vitamin E in multi-vitamin tablets is characterized in that enzymolysis is adopted for pretreatment, and the method comprises the following steps:
step 1, adding water to wet a sample of the multidimensional sheet, adding a predetermined amount of protease, and shaking up to obtain a mixed sample I;
step 2, placing the mixed sample I in a water bath with a preset temperature for ultrasonic preset time, and then adding a preset amount of ethanol to obtain a mixed sample II;
step 3, continuing ultrasonic treatment on the mixed sample II at the preset temperature for preset time, cooling to room temperature, and diluting with ethanol to obtain a mixed sample III;
and 4, filtering the mixed sample III, detecting by adopting HPLC, and calculating based on a reference substance detected by adopting HPLC to obtain the content of the vitamin E in the sample.
2. The method for detecting vitamin E in a multi-dimensional tablet according to claim 1, wherein:
wherein the preset temperature in the step 2 and the step 3 is 60-65 ℃,
the predetermined time in step 2 and step 3 is 20 min.
3. The method for detecting vitamin E in a multi-dimensional tablet according to claim 1, wherein:
wherein the volume-mass ratio of the protease added in the step 1 to the sample is 1: 1-5: 1.
4. The method for detecting vitamin E in a multi-dimensional tablet according to claim 1, wherein:
wherein the enzymatic activity of the protease used in the step 1 is more than or equal to 3 AU-A/g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010273583.0A CN112067707A (en) | 2020-04-09 | 2020-04-09 | Method for detecting vitamin E in multi-vitamin tablets |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010273583.0A CN112067707A (en) | 2020-04-09 | 2020-04-09 | Method for detecting vitamin E in multi-vitamin tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112067707A true CN112067707A (en) | 2020-12-11 |
Family
ID=73658675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010273583.0A Pending CN112067707A (en) | 2020-04-09 | 2020-04-09 | Method for detecting vitamin E in multi-vitamin tablets |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112067707A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102253130A (en) * | 2010-12-24 | 2011-11-23 | 天津天狮生物发展有限公司 | Method for measuring vitamins A, D and E in compound vitamin |
CN105510454A (en) * | 2015-11-24 | 2016-04-20 | 威海百合生物技术股份有限公司 | A method of rapidly measuring vitamin E in a healthcare product |
-
2020
- 2020-04-09 CN CN202010273583.0A patent/CN112067707A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102253130A (en) * | 2010-12-24 | 2011-11-23 | 天津天狮生物发展有限公司 | Method for measuring vitamins A, D and E in compound vitamin |
CN105510454A (en) * | 2015-11-24 | 2016-04-20 | 威海百合生物技术股份有限公司 | A method of rapidly measuring vitamin E in a healthcare product |
Non-Patent Citations (1)
Title |
---|
叶燕: "几种保健食品中特定功效成分的质量标准初探", 《中国优秀博硕士学位论文全文数据库(硕士)工程科技Ⅰ辑》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brubacher | Methods for the Determination of Vitamins in Food: Recommended by COST 91 | |
Erlund et al. | Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice | |
Alaburda et al. | Determination of folic acid in fortified wheat flours | |
Cabezudo et al. | Soybean (Glycine max) hull valorization through the extraction of polyphenols by green alternative methods | |
CN106855545B (en) | Method for simultaneously detecting fat-soluble vitamins and water-soluble vitamins in feed | |
CN105004811A (en) | Chromatographic analysis method for efficiently and rapidly determining group B vitamin content in complex component | |
CN108642117B (en) | Method for extracting limonin and nomilin | |
CN110632203A (en) | Synchronous and rapid detection of vitamin A and vitamin D3And vitamin E | |
CN105861235A (en) | Method for reducing urea in fermented grains of Luzhou-flavor liquor | |
Wang et al. | pH-controlled reversible deep-eutectic solvent based enzyme system for simultaneous extraction and in-situ separation of isoflavones from Pueraria lobata | |
Wang et al. | Variable isoflavone content of red clover products affects intestinal disposition of biochanin A, formononetin, genistein, and daidzein | |
Lee et al. | Rapid quantification of cellular flavonoid levels using quercetin and a fluorescent diphenylboric acid 2-amino ethyl ester probe | |
CN112067707A (en) | Method for detecting vitamin E in multi-vitamin tablets | |
CN105815707A (en) | Green kumquat powder as well as preparation method and purpose thereof | |
Hsia et al. | Downregulation of progesterone biosynthesis in rat granulosa cells by adlay (Coix lachryma-jobi L. var. ma-yuen Stapf.) bran extracts | |
Ren et al. | Unraveling the Water Source and Formation Process of Huangshui in Solid-State Fermentation | |
Hagar et al. | Reversed-phase liquid chromatographic determination of vitamin D in milk | |
CN112067706A (en) | Method for detecting vitamin D in multi-dimensional tablets | |
Chu et al. | Bitter flavors and bitter compounds in foods: identification, perception, and reduction techniques | |
CN110568110B (en) | Method for measuring antioxidant content in high-oxidation-resistance fat emulsion injection | |
CN105876596A (en) | Bitterness removing method of citrus juice | |
CN111693615B (en) | Analytical method for simultaneous determination of niacin, vitamin B1, B6 and pantothenic acid | |
CN106918661A (en) | A kind of high-performance liquid chromatogram determination method for determining Ah Ti woods C content in Detection of Brazilian Propolis soft capsule | |
CN103224545B (en) | Sulfur-containing compound with nerve protection effect and application thereof | |
CN111537642A (en) | Method for determining alpha-vitamin E in beverage by utilizing solid phase extraction-liquid chromatography |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201211 |